Pamela M. Arway
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
AI boom boosts IRM as REITs gain from data demand. Iron Mountain is highlighted in a Yahoo article that links the rapid growth of AI to increased demand for data center space, benefiting several REITs including IRM. The company also announced its third‑quarter 2026 earnings release and conference call, giving investors a chance to review its performance. A separate piece noted that REITs overall are outperforming the market, which may support IRM’s position in the sector.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HSY faces higher candy costs and mixed analyst outlook. Seasonal candy prices have risen sharply, which could pressure Hershey's margins as Halloween demand climbs. Analysts have adjusted price targets lower, with JP Morgan and TD Cowen maintaining neutral or buy views while reducing their forecasts. The company's dividend yield of about 2.5% keeps it in focus among defensive dividend stocks.
Transaction History
| DVA | ▲ Buy | Grant | 278 | $0 | 8/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 250 | $0 | 5/15/2026 | View on chart |
| IRM | ▼ Sell | Open Market | 1,892 | $244K | 5/12/2026 | View on chart |
| IRM | ▲ Buy | Grant | 1,892 | $0 | 5/7/2026 | View on chart |
| DVA | ▲ Buy | Grant | 332 | $0 | 3/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 411 | $0 | 11/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 369 | $0 | 8/15/2025 | View on chart |
| IRM | ▲ Buy | Grant | 2,249 | $0 | 5/29/2025 | View on chart |
| DVA | ▲ Buy | Grant | 348 | $0 | 5/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 349 | $0 | 3/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 312 | $0 | 11/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 333 | $0 | 8/15/2024 | View on chart |
| IRM | ▲ Buy | Grant | 2,385 | $24 | 5/30/2024 | View on chart |
| DVA | ▲ Buy | Grant | 363 | $0 | 5/15/2024 | View on chart |
| HSY | ▲ Buy | Grant | 220 | $0 | 4/1/2024 | View on chart |
| DVA | ▲ Buy | Grant | 366 | $0 | 3/15/2024 | View on chart |
| HSY | ▲ Buy | Grant | 271 | $0 | 1/1/2024 | View on chart |
| DVA | ▲ Buy | Grant | 529 | $0 | 11/15/2023 | View on chart |
| HSY | ▼ Sell | Open Market | 182 | $35K | 10/9/2023 | View on chart |
| HSY | ▲ Buy | Grant | 211 | $0 | 10/1/2023 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 8/15/2023 | View on chart |
| HSY | ▼ Sell | Open Market | 187 | $45K | 7/11/2023 | View on chart |
| HSY | ▲ Buy | Grant | 170 | $0 | 7/1/2023 | View on chart |
| DVA | ▲ Buy | Grant | 516 | $0 | 5/15/2023 | View on chart |
| IRM | ▲ Buy | Grant | 3,047 | $30 | 5/9/2023 | View on chart |
| HSY | ▼ Sell | Open Market | 188 | $49K | 4/10/2023 | View on chart |
| HSY | ▲ Buy | Grant | 168 | $0 | 4/1/2023 | View on chart |
| DVA | ▲ Buy | Grant | 658 | $0 | 3/15/2023 | View on chart |
| HSY | ▼ Sell | Open Market | 211 | $48K | 1/10/2023 | View on chart |
| HSY | ▲ Buy | Grant | 183 | $0 | 1/1/2023 | View on chart |
| DVA | ▲ Buy | Grant | 677 | $0 | 11/15/2022 | View on chart |
| HSY | ▼ Sell | Open Market | 239 | $53K | 10/7/2022 | View on chart |
| HSY | ▲ Buy | Grant | 179 | $0 | 10/1/2022 | View on chart |
| DVA | ▲ Buy | Grant | 514 | $0 | 8/15/2022 | View on chart |
| HSY | ▼ Sell | Open Market | 234 | $52K | 7/8/2022 | View on chart |
| HSY | ▲ Buy | Grant | 184 | $0 | 7/1/2022 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 5/15/2022 | View on chart |
| IRM | ▲ Buy | Grant | 3,300 | $33 | 5/10/2022 | View on chart |
| HSY | ▼ Sell | Open Market | 255 | $57K | 4/7/2022 | View on chart |
| HSY | ▲ Buy | Grant | 185 | $0 | 4/1/2022 | View on chart |
| DVA | ▲ Buy | Grant | 429 | $0 | 3/15/2022 | View on chart |
| HSY | ▼ Sell | Open Market | 269 | $53K | 1/7/2022 | View on chart |
| HSY | ▲ Buy | Grant | 208 | $0 | 1/1/2022 | View on chart |
| DVA | ▼ Sell | Open Market | 446 | $46K | 11/23/2021 | View on chart |
| DVA | ▲ Buy | Grant | 446 | $0 | 11/15/2021 | View on chart |
| HSY | ▼ Sell | Open Market | 288 | $52K | 10/7/2021 | View on chart |
| HSY | ▲ Buy | Grant | 235 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer
Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer. Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.